Equities

Lionco Pharmaceutical Group Co Ltd

603669:SHH

Lionco Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)6.04
  • Today's Change-0.16 / -2.58%
  • Shares traded41.00m
  • 1 Year change+6.71%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7059531,550
Total Receivables, Net84108151
Total Inventory574952
Prepaid expenses6.269.6120
Other current assets, total291316
Total current assets8821,1321,788
Property, plant & equipment, net505496485
Goodwill, net--02.03
Intangibles, net108116124
Long term investments1078576
Note receivable - long term------
Other long term assets------
Total assets1,6251,8552,514
LIABILITIES
Accounts payable554829
Accrued expenses131425
Notes payable/short-term debt157224493
Current portion long-term debt/capital leases3.021.1488
Other current liabilities, total141613
Total current liabilities243302649
Total long term debt445414401
Total debt605638982
Deferred income tax2.420.220.19
Minority interest------
Other liabilities, total2.804.095.81
Total liabilities6947201,056
SHAREHOLDERS EQUITY
Common stock721721721
Additional paid-in capital256256256
Retained earnings (accumulated deficit)(32)120388
Treasury stock - common(108)(56)--
Unrealized gain (loss)------
Other equity, total949494
Total equity9311,1351,459
Total liabilities & shareholders' equity1,6251,8552,514
Total common shares outstanding718718721
Treasury shares - common primary issue3.623.620
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.